TRANSCODE THERAPEUTICS INC (RNAZ)
US89357L3033 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -18.55M | -17.56M | -6.84M | -2.34M | -610.00K | |||
| Depreciation Amortization | 123.48K | 100.00K | 40.00K | N/A | N/A | |||
| Change In Working Capital | -1.08M | 1.34M | 400.00K | 310.00K | 0.00 | |||
| Interest Paid | 32.86K | 40.00K | 20.00K | 0.00 | 0.00 | |||
| Taxes Paid | N/A | N/A | 0.00 | 0.00 | 0.00 | |||
| Other non cash items | 1.43M | 360.00K | 1.13M | 1.54M | 100.00K | |||
| OPERATING CASH FLOW | -18.07M | -15.76M | -5.27M | -490.00K | -510.00K | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -35.61K | -100.00K | -250.00K | N/A | N/A | |||
| Other Investing Activity | N/A | 0.00 | 0.00 | N/A | N/A | |||
| INVESTING CASH FLOW | -35.61K | -100.00K | -250.00K | N/A | N/A | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | N/A | 0.00 | 1.19M | 500.00K | |||
| Stock Issued/Repurchased | 15.91M | 10.00K | 26.35M | N/A | N/A | |||
| Other Financing Activity | N/A | 0.00 | -830.00K | -70.00K | 0.00 | |||
| FINANCING CASH FLOW | 15.91M | 10.00K | 25.52M | 1.12M | 500.00K | |||
| CHANGE IN CASH | -2.20M | -15.85M | 20.00M | 620.00K | -10.00K | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -18.07M | -15.76M | -5.27M | -490.00K | -510.00K | |||
| Capital Expenditure | -35.61K | -100.00K | -250.00K | N/A | N/A | |||
| FREE CASH FLOW | -18.11M | -15.86M | -5.52M | -490.00K | -510.00K | |||
All data in USD